Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
Wet Biomarkers -
datedescriptionsizeauthor document 
06.12.12Establishment of novel assays for quantification of full-length wild-type and mutant Huntingtin by using the AlphaLISA technology1.4 MBblankinapplication/pdf
06.12.12Selisistat: Soluble htt protein levels as a potential pharmacodynamic readout1.4 MBblankinapplication/pdf
06.12.12Whole blood SAGE digital gene expression profiling from Huntington's disease patients1.5 MBblankinapplication/pdf
06.12.12Selisistat: potential pharmacodynamic readouts based on transcriptomics1.2 MBblankinapplication/pdf
06.12.12Mutant Huntingtin fragmentation in immune cells tracks Huntington’s Disease progression1.1 MBblankinapplication/pdf
06.12.12A critical evaluation of inflammatory markers in Huntington’s Disease plasma1.2 MBblankinapplication/pdf
06.12.12Cross-sectional and longitudinal associations between CRP and neuropsychiatric symptoms in HD1.5 MBblankinapplication/pdf
06.12.12The autoimmune profile of Huntington`s Disease patients - a pilot study1.8 MBblankinapplication/pdf
06.12.12The study on molecular changes related to energy metabolism in Huntington’s disease subjects - looking for biomarkers1.6 MBblankinapplication/pdf
06.12.12Progredient deterioration of hepatic mitochondrial function in Huntington's Disease – measured by using the 13C-methionin breath test1.1 MBblankinapplication/pdf
06.12.12Abnormal regulation of macrophage-derived transforming growth factor – β 1 (TGF-β1) production in Huntington Disease1.1 MBblankinapplication/pdf
06.12.128OHdG is not a biomarker for Huntington’s Disease; lessons for future biomarker studies1.7 MBblankinapplication/pdf
06.12.12A new biomarker in Huntington's disease900 kBblankinapplication/pdf

Folder contains 13 documents.